UBE2V2 Antikörper (AA 2-145) (Biotin)
Kurzübersicht für UBE2V2 Antikörper (AA 2-145) (Biotin) (ABIN7174496)
Target
Alle UBE2V2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 2-145
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 protein (2-145AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))
- 
                                            Andere Bezeichnung
- UBE2V2
- 
                                            Hintergrund
- 
                        Background: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through \'Lys-63\'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage. Aliases: 1 alpha 25 dihydroxyvitamin D3 inducible antibody, DDVit 1 antibody, DDVIT1 antibody, EDAF-1 antibody, EDAF1 antibody, EDPF-1 antibody, EDPF1 antibody, Enterocyte differentiation associated factor EDAF 1 antibody, Enterocyte differentiation promoting factor antibody, Enterocyte differentiation-associated factor 1 antibody, Enterocyte differentiation-promoting factor 1 antibody, Methyl methanesulfonate sensitive 2 antibody, MMS 2 antibody, MMS2 antibody, MMS2 homolog antibody, UB2V2_HUMAN antibody, UBE2V 2 antibody, UBE2V2 antibody, Ubiquitin conjugating enzyme E2 variant 2 antibody, Ubiquitin conjugating enzyme E2v2 antibody, Ubiquitin-conjugating enzyme E2 variant 2 antibody, UEV 2 antibody, UEV2 antibody, Vitamin D3 inducible protein antibody, Vitamin D3-inducible protein antibody 
- 
                                            UniProt
- Q15819
- 
                                            Pathways
- Positive Regulation of Response to DNA Damage Stimulus
 Target
- 
                    
 
                                     
                                     
                                    